Constitutional Law On Patent Law And Innovation.

1. Constitutional Foundations of Patent Law

(a) Article 21 – Right to Life

The Supreme Court has interpreted Article 21 to include:

  • Right to health
  • Right to access essential medicines

πŸ‘‰ Patent protection cannot restrict access to life-saving drugs.

(b) Article 14 – Equality Before Law

Patent laws must:

  • Avoid arbitrary monopolies
  • Ensure fair treatment

For example, unjustified extension of patents (evergreening) can violate equality.

(c) Article 19(1)(g) – Freedom of Trade and Profession

  • Innovators have the right to carry on business
  • But this is subject to reasonable restrictions in public interest

πŸ‘‰ Patent rights are not absolute.

(d) Directive Principles of State Policy (DPSPs)

  • Article 39(b) – Resources distributed for common good
  • Article 47 – Duty of the State to improve public health

πŸ‘‰ These principles justify limiting patent rights for public welfare.

2. Nature of Patent Rights in Constitutional Context

  • Patents are statutory rights, not fundamental rights
  • They grant temporary monopoly (usually 20 years)
  • Purpose:
    • Encourage innovation
    • Reward inventors
    • Promote technological progress

βš–οΈ Constitutional balance:
Innovation incentives vs Public access

3. Key Doctrines in Patent Law

(a) Public Interest Doctrine

State can override patents for:

  • Public health emergencies
  • National interest

(b) Compulsory Licensing

Allows government to:

  • Permit third parties to produce patented products
  • Ensure affordability

(c) Anti-Evergreening Principle

Prevents:

  • Minor modifications being patented repeatedly
  • Artificial extension of monopoly

4. Landmark Case Laws

1. Novartis AG v. Union of India

  • Concerned patent for cancer drug Glivec
  • Supreme Court rejected patent due to lack of β€œenhanced efficacy”

πŸ‘‰ Established:

  • Strong stance against evergreening
  • Prioritized public access to medicines

2. Bayer Corporation v. Union of India

  • First compulsory license granted in India
  • Drug: Nexavar (cancer treatment)

πŸ‘‰ Court held:

  • High prices violate public interest
  • Affordable access is essential

3. Roche v. Cipla

  • Issue: Patent infringement vs access to medicine

πŸ‘‰ Court emphasized:

  • Balance between patent rights and public health
  • Interim relief must consider affordability

4. F. Hoffmann-La Roche Ltd. v. Cipla Ltd.

  • Continued dispute over cancer drug patents

πŸ‘‰ Reinforced:

  • Public interest outweighs strict patent enforcement

5. Monsanto Technology LLC v. Nuziveedu Seeds Ltd.

  • Concerned genetically modified seeds

πŸ‘‰ Court observed:

  • Patent rights must align with farmers’ rights
  • Innovation must not harm agricultural sustainability

6. Entertainment Network India Ltd. v. Super Cassette Industries Ltd.

  • Though a copyright case, it clarified:

πŸ‘‰ Intellectual property rights are:

  • Statutory rights
  • Subject to public interest and regulation

7. AstraZeneca AB v. Intas Pharmaceuticals Ltd.

  • Addressed pharmaceutical patent disputes

πŸ‘‰ Court stressed:

  • Strict scrutiny of patent claims
  • Prevent misuse of monopoly

5. Constitutional Balancing Approach

Courts in India follow a balancing test:

InterestProtection
InnovatorsPatent rights, incentives
PublicAccess to medicines, affordability
StateEconomic growth, public welfare

6. Role of the Judiciary

Indian courts act as guardians of constitutional balance by:

  • Preventing abuse of patent rights
  • Promoting access to essential goods
  • Encouraging genuine innovation

7. Challenges in Patent Law and Innovation

(a) High Cost of Medicines

  • Patents can lead to monopolistic pricing

(b) Evergreening

  • Minor changes to extend patents

(c) Technology Access Gap

  • Developing countries struggle to access innovations

(d) Global Pressure (TRIPS Agreement)

  • Balancing international obligations with domestic needs

8. Conclusion

Patent law in India is shaped by constitutional values of:

  • Justice
  • Equality
  • Public welfare

Cases like Novartis AG v. Union of India and Bayer Corporation v. Union of India clearly show that:

πŸ‘‰ Innovation is encouraged, but not at the cost of human life and dignity.

The Indian constitutional framework ensures that patent protection serves society, not just private profit.

LEAVE A COMMENT